Wound Care Market (Traditional Wound Care, Advanced Wound Care, Active Wound Care, Negative Pressure Wound Therapy & Other Therapy Devices)
Wound Care Market (Traditional Wound Care, Advanced Wound Care, Active Wound Care, Negative Pressure Wound Therapy & Other Therapy Devices) - Current Trends, Opportunities & Global Forecasts (2011 – 2016)
A wound is an injury or break in the skin, generally a dissection of tissue or rupture of a membrane, due to external aggression or some involuntary activity other than disease. Wound care has evolved from traditional wound care, advanced wound care, active wound care to therapy devices. Traditional wound care includes products such as dry dressings, bandages, etc. Advanced wound care product constitutes of alginates, hydrogels, hydrocolloids and collagen. Active wound care products include skin substitutes and biological growth factors. The therapy device market consists of NPWT, HBOT, Whirlpool therapy, ultrasound therapy, ultraviolet, etc.
The wound care market is driven by increase in the ageing population, rise in chronic diseases (such as diabetes and hypertension), and technological advancements. The demand for portable and easy to use devices is expected to drive the growth of the wound care market in the coming years. At the same time, tissue-engineered products like skin substitutes and biological growth factors are expected to drive the market in the long term.
Rapid breakthrough in wound-healing technologies to develop cost effective treatment is expected to drive the growth of the market. Companies are now focusing on the introduction of advanced materials, methods, and active substances for the treatment of wounds. For example, Smith and Nephew launched in January 2012 a pocket-sized PICO system, a single use Negative Pressure Wound Therapy (NPWT) system, across the U.S., Europe, Canada, and Australia. The PICO system's one-button pump is easy-to-use and its small size and silent operation provides a discreet, unobtrusive way to carry on daily life with NPWT.
The U.S. constitutes the biggest market for wound care products and devices, followed by Europe, Asia and ROW. The rising number of chronic diseases and ageing population has boosted the demand for this market. The pricing and reimbursement issue is one of the major factors hampering the growth of this market. The Asian region is expected to witness moderate growth, mainly due to lack of reimbursement, forcing physicians and patient to opt for traditional treatment. The overall wound care market is also expected to foresee moderate growth – relatively higher growth will be seen in advanced wound care products, tissue engineered products, and negative pressure relief devices.
Major players in the wound care market include, Kinetic Concepts, Inc (U.S.), Smith and Nephew (U.K.), ConvaTec Inc (Luxembourg), Molnlycke Healthcare (Sweden), and Systagenix (U.K.).
Scope of world wound care market
By types
A wound is an injury or break in the skin, generally a dissection of tissue or rupture of a membrane, due to external aggression or some involuntary activity other than disease. Wound care has evolved from traditional wound care, advanced wound care, active wound care to therapy devices. Traditional wound care includes products such as dry dressings, bandages, etc. Advanced wound care product constitutes of alginates, hydrogels, hydrocolloids and collagen. Active wound care products include skin substitutes and biological growth factors. The therapy device market consists of NPWT, HBOT, Whirlpool therapy, ultrasound therapy, ultraviolet, etc.
The wound care market is driven by increase in the ageing population, rise in chronic diseases (such as diabetes and hypertension), and technological advancements. The demand for portable and easy to use devices is expected to drive the growth of the wound care market in the coming years. At the same time, tissue-engineered products like skin substitutes and biological growth factors are expected to drive the market in the long term.
Rapid breakthrough in wound-healing technologies to develop cost effective treatment is expected to drive the growth of the market. Companies are now focusing on the introduction of advanced materials, methods, and active substances for the treatment of wounds. For example, Smith and Nephew launched in January 2012 a pocket-sized PICO system, a single use Negative Pressure Wound Therapy (NPWT) system, across the U.S., Europe, Canada, and Australia. The PICO system's one-button pump is easy-to-use and its small size and silent operation provides a discreet, unobtrusive way to carry on daily life with NPWT.
The U.S. constitutes the biggest market for wound care products and devices, followed by Europe, Asia and ROW. The rising number of chronic diseases and ageing population has boosted the demand for this market. The pricing and reimbursement issue is one of the major factors hampering the growth of this market. The Asian region is expected to witness moderate growth, mainly due to lack of reimbursement, forcing physicians and patient to opt for traditional treatment. The overall wound care market is also expected to foresee moderate growth – relatively higher growth will be seen in advanced wound care products, tissue engineered products, and negative pressure relief devices.
Major players in the wound care market include, Kinetic Concepts, Inc (U.S.), Smith and Nephew (U.K.), ConvaTec Inc (Luxembourg), Molnlycke Healthcare (Sweden), and Systagenix (U.K.).
Scope of world wound care market
By types
- Traditional wound care
- Wound closure
- Sutures
- By types
- Absorbable
- Non-absorbable
- By materials
- Natural
- Synthetic
- Staples & staplers
- Adhesives, sealants & glues
- Fibrin based
- Collagen based
- Synthetic adhesives & glues
- Basic wound care
- Dry dressing
- Tapes
- Cleansing solutions
- Anti-infectives
- Advanced wound care
- Films
- Foams
- Hydrocolloids
- Hydrogels
- Collagen
- Alginates
- Active wound care
- Skin substitutes
- Growth factors
- Therapy devices
- Negative Pressure Wound Therapy (NPWT)
- Pressure relief devices
- Oxygen & hyperbaric oxygen therapy devices
- Ultraviolet therapy devices
- Electromagnetic therapy devices
- Electrical stimulation devices
- Whirlpool therapy devices
- Ultrasound therapy devices
- Low intensity laser therapy devices
- Ulcers major
- Pressure ulcers
- Diabetic ulcers
- Venous ulcers
- Arterial ulcers
- Burns
- Surgical wounds
- Hospitals
- Community health services
- U.S.
- Europe
- Asia
- Rest of the World (ROW)
1 INTRODUCTION
1.1 KEY TAKE-AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
1.5.1 MARKET SIZE
1.5.2 MARKET SHARE
1.5.3 KEY DATA POINTS FROM SECONDARY SOURCE
1.5.4 KEY DATA POINTS FORM PRIMARY SOURCES
1.5.5 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 MARKET OVERVIEW
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 MARKET DYNAMICS
3.3.1 DRIVERS
3.3.1.1 Rapidly aging population proves to be an impetus for growth of the wound care market
3.3.1.2 Rising incidence of chronic diseases to spur market growth
3.3.1.3 Technical advances to boost market growth
3.3.2 RESTRAINTS
3.3.2.1 Unfavorable reimbursement scenario to curb the growth of the wound care market
3.3.2.2 Reluctance to adopt new technologies likely to hinder market growth
3.4 END-USER ANALYSIS
3.5 MARKET SHARE ANALYSIS
4 WORLD WOUND CARE MARKET, BY PRODUCTS
4.1 INTRODUCTION
4.2 TRADITIONAL WOUND CARE MARKET
4.2.1 WOUND-CLOSURE PRODUCTS
4.2.1.1 Sutures
4.2.1.1.1 Absorbable
4.2.1.1.1.1 Surgical gut (Catgut)
4.2.1.1.1.2 Synthetic absorbable polymers
4.2.1.1.2 Non-absorbable sutures
4.2.1.1.2.1 Surgical silk
4.2.1.1.2.2 Surgical cotton
4.2.1.1.2.3 Linen
4.2.1.1.2.4 Synthetic non-absorbable polymers
4.2.1.1.3 Staplers and staples
4.2.2 TISSUE ADHESIVES, SEALANTS & GLUES
4.2.2.1 Fibrin-based sealant
4.2.2.2 Collagen-based sealant
4.2.2.3 Synthetic adhesives/glues
4.2.3 ANTI-INFECTIVES
4.3 BASIC WOUND CARE
4.3.1 TAPES
4.3.2 DRY DRESSINGS
4.3.3 CLEANSING
4.4 ADVANCED WOUND CARE
4.4.1 FILMS
4.4.2 FOAM DRESSINGS
4.4.3 COLLAGEN
4.4.4 ALGINATES
4.4.5 HYDROCOLLOIDS
4.4.6 HYDROGELS
4.5 ACTIVE WOUND CARE
4.5.1 ARTIFICIAL SKIN & SKIN SUBSTITUTES
4.5.1.1 Skin substitutes
4.5.2 BIOLOGICAL GROWTH FACTORS
4.6 THERAPY DEVICES
4.6.1 NEGATIVE PRESSURE WOUND THERAPY DEVICES (NPWT)
4.6.2 PRESSURE RELIEF DEVICES
4.6.3 ELECTRICAL STIMULATION DEVICES
4.6.4 ULTRAVIOLET DEVICES
4.6.5 OXYGEN & HYPERBARIC OXYGEN
4.6.6 WHIRLPOOL THERAPY
4.6.7 ELECTROMAGNETIC THERAPY DEVICE
4.6.8 ULTRASOUND
4.6.9 LOW INTENSITY LASER THERAPY
5 WORLD WOUND CARE MARKET, BY APPLICATIONS
5.1 TYPES OF WOUNDS
5.1.1 SKIN ULCERS
5.1.1.1 Pressure or decubitus ulcers
5.1.1.2 Diabetic ulcers or neuropathic ulcers
5.1.1.3 Arterial ulcers
5.1.1.4 Venous ulcers
5.1.2 BURNS
5.1.2.1 Thermal injury
5.1.2.2 Chemical injury
5.1.2.3 Electrical injury
5.1.2.4 Classification by depth of burns
5.1.2.5 First-degree burns
5.1.2.6 Superficial partial-thickness burns (second-degree)
5.1.2.7 Deep partial thickness burns
5.1.2.8 Full-thickness burns (third and fourth-degree)
5.1.3 SURGICAL WOUNDS
5.1.3.1 Trauma wounds
6 GEOGRAPHICAL ANALYSIS
6.1 INTRODUCTION
6.2 U.S.
6.2.1 COMPETITIVE LANDSCAPE
6.3 EUROPE
6.3.1 COMPETITIVE LANDSCAPE
6.4 ASIA
6.4.1 COMPETITIVE LANDSCAPE
6.5 ROW
7 COMPETITIVE LANDSCAPE
7.1 INTRODUCTION
7.2 MERGERS & ACQUISITIONS
7.3 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, JOINT VENTURES
7.4 NEW PRODUCTS LAUNCH
7.5 EXPANSIONS
8 COMPANY PROFILES
8.1 3M COMPANY
8.1.1 OVERVIEW
8.1.2 FINANCIALS
8.1.3 PRODUCTS & SERVICES
8.1.4 STRATEGY
8.1.5 DEVELOPMENTS
8.2 BAXTER INTERNATIONAL INC.
8.2.1 OVERVIEW
8.2.2 FINANCIALS
8.2.3 PRODUCTS & SERVICES
8.2.4 STRATEGY
8.2.5 DEVELOPMENTS
8.3 BSN MEDICAL GMBH AND CO KG
8.3.1 OVERVIEW
8.3.2 FINANCIALS
8.3.3 PRODUCTS & SERVICES
8.3.4 STRATEGY
8.3.5 DEVELOPMENTS
8.4 COLOPLAST A/S
8.4.1 OVERVIEW
8.4.2 FINANCIALS
8.4.3 PRODUCTS & SERVICES
8.4.4 STRATEGY
8.4.5 DEVELOPMENTS
8.5 CONVATEC HEALTHCARE B S.A.R.L
8.5.1 OVERVIEW
8.5.2 FINANCIALS
8.5.3 PRODUCTS & SERVICES
8.5.4 STRATEGY
8.5.5 DEVELOPMENTS
8.6 COVIDIEN PLC.
8.6.1 OVERVIEW
8.6.2 FINANCIALS
8.6.3 PRODUCTS & SERVICES
8.6.4 STRATEGY
8.6.5 DEVELOPMENTS
8.7 DERMA SCIENCES INC.
8.7.1 OVERVIEW
8.7.2 FINANCIALS
8.7.3 PRODUCTS & SERVICES
8.7.4 STRATEGY
8.7.5 DEVELOPMENTS
8.8 HILL-ROM HOLDINGS INC.
8.8.1 OVERVIEW
8.8.2 FINANCIALS
8.8.3 PRODUCTS & SERVICES
8.8.4 STRATEGY
8.8.5 DEVELOPMENTS
8.9 HOLLISTER INCORPORATED
8.9.1 OVERVIEW
8.9.2 FINANCIALS
8.9.3 PRODUCTS & SERVICES
8.9.4 STRATEGY
8.9.5 DEVELOPMENTS
8.10 HUMAN BIOSCIENCES INC.
8.10.1 OVERVIEW
8.10.2 FINANCIALS
8.10.3 PRODUCTS & SERVICES
8.10.4 STRATEGY
8.10.5 DEVELOPMENTS
8.11 JOHNSON AND JOHNSON
8.11.1 OVERVIEW
8.11.2 FINANCIALS
8.11.3 PRODUCTS & SERVICES
8.11.4 STRATEGY
8.11.5 DEVELOPMENTS
8.12 KINETIC CONCEPTS INC.
8.12.1 OVERVIEW
8.12.2 FINANCIALS
8.12.3 PRODUCTS & SERVICES
8.12.4 STRATEGY
8.12.5 DEVELOPMENTS
8.13 LABORATOIRES URGO
8.13.1 OVERVIEW
8.13.2 FINANCIALS
8.13.3 PRODUCTS & SERVICES
8.13.4 STRATEGY
8.13.5 DEVELOPMENTS
8.14 MEDLINE INDUSTRIES INC.
8.14.1 OVERVIEW
8.14.2 FINANCIALS
8.14.3 PRODUCTS & SERVICES
8.14.4 STRATEGY
8.14.5 DEVELOPMENTS
8.15 MOLNLYCKE HEALTH CARE AB
8.15.1 OVERVIEW
8.15.2 FINANCIALS
8.15.3 PRODUCTS & SERVICES
8.15.4 STRATEGY
8.15.5 DEVELOPMENTS
8.16 PAUL HARTMANN AG
8.16.1 OVERVIEW
8.16.2 FINANCIALS
8.16.3 PRODUCTS & SERVICES
8.16.4 STRATEGY
8.16.5 DEVELOPMENTS
8.17 SHIRE PLC.
8.17.1 OVERVIEW
8.17.2 FINANCIALS
8.17.3 PRODUCTS & SERVICES
8.17.4 STRATEGY
8.17.5 DEVELOPMENTS
8.18 SMITH & NEPHEW PLC.
8.18.1 OVERVIEW
8.18.2 FINANCIALS
8.18.3 PRODUCTS & SERVICES
8.18.4 STRATEGY
8.18.5 DEVELOPMENTS
8.19 SYSTAGENIX WOUND MANAGEMENT LTD.
8.19.1 OVERVIEW
8.19.2 FINANCIALS
8.19.3 PRODUCTS & SERVICES
8.19.4 STRATEGY
8.19.5 DEVELOPMENTS
8.20 ULURU INC.
8.20.1 OVERVIEW
8.20.2 FINANCIALS
8.20.3 PRODUCTS & SERVICES
8.20.4 STRATEGY
8.20.5 DEVELOPMENTS
8.21 WOUND MANAGEMENT TECHNOLOGIES INC.
8.21.1 OVERVIEW
8.21.2 FINANCIALS
8.21.3 PRODUCTS & SERVICES
8.21.4 STRATEGY
8.21.5 DEVELOPMENTS
APPENDIX
ADVANCED WOUND CARE
FOAMS
HYDROGELS
ALGINATES
HYDROCOLLOIDS
ACTIVE WOUND CARE
TRADITIONAL WOUND CARE
NON-ABSORBALE SUTURES
ABSORABLE SUTURES
TISSUE ADHESIVE, GLUES AND SEALANTS
THERAPY DEVICES - NPWT
BIOLOGICAL GROWTH FACTORS
ULTRA SOUND WOUND CARE DEVICES
HYPERBARIC OXYGEN THAERAPY FOR WOUND CARE
WHIRLPOOL THERAPY
PRESSURE RELIEF DEVICES
ELECTROMAGNETIC THERAPY DEVICE
1.1 KEY TAKE-AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
1.5.1 MARKET SIZE
1.5.2 MARKET SHARE
1.5.3 KEY DATA POINTS FROM SECONDARY SOURCE
1.5.4 KEY DATA POINTS FORM PRIMARY SOURCES
1.5.5 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 MARKET OVERVIEW
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 MARKET DYNAMICS
3.3.1 DRIVERS
3.3.1.1 Rapidly aging population proves to be an impetus for growth of the wound care market
3.3.1.2 Rising incidence of chronic diseases to spur market growth
3.3.1.3 Technical advances to boost market growth
3.3.2 RESTRAINTS
3.3.2.1 Unfavorable reimbursement scenario to curb the growth of the wound care market
3.3.2.2 Reluctance to adopt new technologies likely to hinder market growth
3.4 END-USER ANALYSIS
3.5 MARKET SHARE ANALYSIS
4 WORLD WOUND CARE MARKET, BY PRODUCTS
4.1 INTRODUCTION
4.2 TRADITIONAL WOUND CARE MARKET
4.2.1 WOUND-CLOSURE PRODUCTS
4.2.1.1 Sutures
4.2.1.1.1 Absorbable
4.2.1.1.1.1 Surgical gut (Catgut)
4.2.1.1.1.2 Synthetic absorbable polymers
4.2.1.1.2 Non-absorbable sutures
4.2.1.1.2.1 Surgical silk
4.2.1.1.2.2 Surgical cotton
4.2.1.1.2.3 Linen
4.2.1.1.2.4 Synthetic non-absorbable polymers
4.2.1.1.3 Staplers and staples
4.2.2 TISSUE ADHESIVES, SEALANTS & GLUES
4.2.2.1 Fibrin-based sealant
4.2.2.2 Collagen-based sealant
4.2.2.3 Synthetic adhesives/glues
4.2.3 ANTI-INFECTIVES
4.3 BASIC WOUND CARE
4.3.1 TAPES
4.3.2 DRY DRESSINGS
4.3.3 CLEANSING
4.4 ADVANCED WOUND CARE
4.4.1 FILMS
4.4.2 FOAM DRESSINGS
4.4.3 COLLAGEN
4.4.4 ALGINATES
4.4.5 HYDROCOLLOIDS
4.4.6 HYDROGELS
4.5 ACTIVE WOUND CARE
4.5.1 ARTIFICIAL SKIN & SKIN SUBSTITUTES
4.5.1.1 Skin substitutes
4.5.2 BIOLOGICAL GROWTH FACTORS
4.6 THERAPY DEVICES
4.6.1 NEGATIVE PRESSURE WOUND THERAPY DEVICES (NPWT)
4.6.2 PRESSURE RELIEF DEVICES
4.6.3 ELECTRICAL STIMULATION DEVICES
4.6.4 ULTRAVIOLET DEVICES
4.6.5 OXYGEN & HYPERBARIC OXYGEN
4.6.6 WHIRLPOOL THERAPY
4.6.7 ELECTROMAGNETIC THERAPY DEVICE
4.6.8 ULTRASOUND
4.6.9 LOW INTENSITY LASER THERAPY
5 WORLD WOUND CARE MARKET, BY APPLICATIONS
5.1 TYPES OF WOUNDS
5.1.1 SKIN ULCERS
5.1.1.1 Pressure or decubitus ulcers
5.1.1.2 Diabetic ulcers or neuropathic ulcers
5.1.1.3 Arterial ulcers
5.1.1.4 Venous ulcers
5.1.2 BURNS
5.1.2.1 Thermal injury
5.1.2.2 Chemical injury
5.1.2.3 Electrical injury
5.1.2.4 Classification by depth of burns
5.1.2.5 First-degree burns
5.1.2.6 Superficial partial-thickness burns (second-degree)
5.1.2.7 Deep partial thickness burns
5.1.2.8 Full-thickness burns (third and fourth-degree)
5.1.3 SURGICAL WOUNDS
5.1.3.1 Trauma wounds
6 GEOGRAPHICAL ANALYSIS
6.1 INTRODUCTION
6.2 U.S.
6.2.1 COMPETITIVE LANDSCAPE
6.3 EUROPE
6.3.1 COMPETITIVE LANDSCAPE
6.4 ASIA
6.4.1 COMPETITIVE LANDSCAPE
6.5 ROW
7 COMPETITIVE LANDSCAPE
7.1 INTRODUCTION
7.2 MERGERS & ACQUISITIONS
7.3 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, JOINT VENTURES
7.4 NEW PRODUCTS LAUNCH
7.5 EXPANSIONS
8 COMPANY PROFILES
8.1 3M COMPANY
8.1.1 OVERVIEW
8.1.2 FINANCIALS
8.1.3 PRODUCTS & SERVICES
8.1.4 STRATEGY
8.1.5 DEVELOPMENTS
8.2 BAXTER INTERNATIONAL INC.
8.2.1 OVERVIEW
8.2.2 FINANCIALS
8.2.3 PRODUCTS & SERVICES
8.2.4 STRATEGY
8.2.5 DEVELOPMENTS
8.3 BSN MEDICAL GMBH AND CO KG
8.3.1 OVERVIEW
8.3.2 FINANCIALS
8.3.3 PRODUCTS & SERVICES
8.3.4 STRATEGY
8.3.5 DEVELOPMENTS
8.4 COLOPLAST A/S
8.4.1 OVERVIEW
8.4.2 FINANCIALS
8.4.3 PRODUCTS & SERVICES
8.4.4 STRATEGY
8.4.5 DEVELOPMENTS
8.5 CONVATEC HEALTHCARE B S.A.R.L
8.5.1 OVERVIEW
8.5.2 FINANCIALS
8.5.3 PRODUCTS & SERVICES
8.5.4 STRATEGY
8.5.5 DEVELOPMENTS
8.6 COVIDIEN PLC.
8.6.1 OVERVIEW
8.6.2 FINANCIALS
8.6.3 PRODUCTS & SERVICES
8.6.4 STRATEGY
8.6.5 DEVELOPMENTS
8.7 DERMA SCIENCES INC.
8.7.1 OVERVIEW
8.7.2 FINANCIALS
8.7.3 PRODUCTS & SERVICES
8.7.4 STRATEGY
8.7.5 DEVELOPMENTS
8.8 HILL-ROM HOLDINGS INC.
8.8.1 OVERVIEW
8.8.2 FINANCIALS
8.8.3 PRODUCTS & SERVICES
8.8.4 STRATEGY
8.8.5 DEVELOPMENTS
8.9 HOLLISTER INCORPORATED
8.9.1 OVERVIEW
8.9.2 FINANCIALS
8.9.3 PRODUCTS & SERVICES
8.9.4 STRATEGY
8.9.5 DEVELOPMENTS
8.10 HUMAN BIOSCIENCES INC.
8.10.1 OVERVIEW
8.10.2 FINANCIALS
8.10.3 PRODUCTS & SERVICES
8.10.4 STRATEGY
8.10.5 DEVELOPMENTS
8.11 JOHNSON AND JOHNSON
8.11.1 OVERVIEW
8.11.2 FINANCIALS
8.11.3 PRODUCTS & SERVICES
8.11.4 STRATEGY
8.11.5 DEVELOPMENTS
8.12 KINETIC CONCEPTS INC.
8.12.1 OVERVIEW
8.12.2 FINANCIALS
8.12.3 PRODUCTS & SERVICES
8.12.4 STRATEGY
8.12.5 DEVELOPMENTS
8.13 LABORATOIRES URGO
8.13.1 OVERVIEW
8.13.2 FINANCIALS
8.13.3 PRODUCTS & SERVICES
8.13.4 STRATEGY
8.13.5 DEVELOPMENTS
8.14 MEDLINE INDUSTRIES INC.
8.14.1 OVERVIEW
8.14.2 FINANCIALS
8.14.3 PRODUCTS & SERVICES
8.14.4 STRATEGY
8.14.5 DEVELOPMENTS
8.15 MOLNLYCKE HEALTH CARE AB
8.15.1 OVERVIEW
8.15.2 FINANCIALS
8.15.3 PRODUCTS & SERVICES
8.15.4 STRATEGY
8.15.5 DEVELOPMENTS
8.16 PAUL HARTMANN AG
8.16.1 OVERVIEW
8.16.2 FINANCIALS
8.16.3 PRODUCTS & SERVICES
8.16.4 STRATEGY
8.16.5 DEVELOPMENTS
8.17 SHIRE PLC.
8.17.1 OVERVIEW
8.17.2 FINANCIALS
8.17.3 PRODUCTS & SERVICES
8.17.4 STRATEGY
8.17.5 DEVELOPMENTS
8.18 SMITH & NEPHEW PLC.
8.18.1 OVERVIEW
8.18.2 FINANCIALS
8.18.3 PRODUCTS & SERVICES
8.18.4 STRATEGY
8.18.5 DEVELOPMENTS
8.19 SYSTAGENIX WOUND MANAGEMENT LTD.
8.19.1 OVERVIEW
8.19.2 FINANCIALS
8.19.3 PRODUCTS & SERVICES
8.19.4 STRATEGY
8.19.5 DEVELOPMENTS
8.20 ULURU INC.
8.20.1 OVERVIEW
8.20.2 FINANCIALS
8.20.3 PRODUCTS & SERVICES
8.20.4 STRATEGY
8.20.5 DEVELOPMENTS
8.21 WOUND MANAGEMENT TECHNOLOGIES INC.
8.21.1 OVERVIEW
8.21.2 FINANCIALS
8.21.3 PRODUCTS & SERVICES
8.21.4 STRATEGY
8.21.5 DEVELOPMENTS
APPENDIX
ADVANCED WOUND CARE
FOAMS
HYDROGELS
ALGINATES
HYDROCOLLOIDS
ACTIVE WOUND CARE
TRADITIONAL WOUND CARE
NON-ABSORBALE SUTURES
ABSORABLE SUTURES
TISSUE ADHESIVE, GLUES AND SEALANTS
THERAPY DEVICES - NPWT
BIOLOGICAL GROWTH FACTORS
ULTRA SOUND WOUND CARE DEVICES
HYPERBARIC OXYGEN THAERAPY FOR WOUND CARE
WHIRLPOOL THERAPY
PRESSURE RELIEF DEVICES
ELECTROMAGNETIC THERAPY DEVICE
LIST OF TABLES
TABLE 1 WORLD WOUND CARE MARKET REVENUE, BY TYPES, 2009 – 2011 ($MILLION)
TABLE 2 WORLD TRADITIONAL WOUND CARE MARKET REVENUE, BY TYPES, 2009 – 2016 ($MILLION)
TABLE 3 TRADITIONAL WOUND CARE MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 4 WORLD WOUND CLOSURE MARKET REVENUE, BY TYPES, 2009 - 2016 ($MILLION)
TABLE 5 WOUND CLOSURE MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 6 WORLD SUTURES MARKET REVENUE, BY TYPES, 2009 – 2016 ($MILLION)
TABLE 7 WORLD SUTURES MARKET REVENUE, BY MATERIALS, 2009 - 2016 ($MILLION)
TABLE 8 TYPES OF SURGICAL SUTURES
TABLE 9 TYPE OF SUTURES & RAW MATERIALS
TABLE 10 CHARACTERISTICS OF ABSORBABLE SUTURES
TABLE 11 TYPES OF COMMERCIAL SUTURES
TABLE 12 CHARACTERISTICS OF SURGICAL SILK SUTURES
TABLE 13 CHARACTERISTICS OF SURGICAL COTTON SUTURE
TABLE 14 CHARACTERISTICS OF LINEN SUTURE
TABLE 15 TYPES & CHARACTERISTICS OF NON-ABSORBABLE SUTURES
TABLE 16 PARTS OF STAPLES
TABLE 17 WORLD TISSUE ADHESIVES, SEALANTS & GLUES MARKET REVENUE, BY PRODUCTS, 2009 – 2016 ($MILLION)
TABLE 18 ANTI-INFECTIVES MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 19 WORLD BASIC WOUND CARE MARKET REVENUE, BY TYPES, 2009 - 2016 ($MILLION)
TABLE 20 BASIC WOUND CARE MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 21 TYPES OF TAPES
TABLE 22 USES OF DRY DRESSING
TABLE 23 TYPES OF WOUND CLEANSERS
TABLE 24 WORLD ADVANCED WOUND CARE MARKET REVENUE, BY PRODUCTS, 2009 – 2016 ($MILLION)
TABLE 25 ADVANCED WOUND CARE MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 26 FILMS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 27 FOAM DRESSINGS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 28 FUNCTIONS OF COLLAGEN
TABLE 29 COLLAGEN MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 30 ALGINATES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 31 HYDROCOLLOIDS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 32 HYDROGELS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 33 WORLD ACTIVE WOUND CARE MARKET REVENUE, BY TYPES, 2009 – 2016 ($MILLION)
TABLE 34 ACTIVE WOUND CARE MARKET, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 35 TYPES OF SKIN GRAFTS
TABLE 36 COMMERCIAL SKIN SUBSTITUTES
TABLE 37 SKIN SUBSTITUTES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 38 TYPES OF GROWTH FACTORS
TABLE 39 GROWTH FACTOR MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 40 WORLD THERAPY DEVICES MARKET REVENUE, BY PRODUCTS, 2009 – 2016 ($MILLION)
TABLE 41 NPWT MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 42 PRESSURE RELIEF DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 43 ELECTRICAL STIMULATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 44 ULTRAVIOLET DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 45 HBOT MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 46 WHIRLPOOL THERAPY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 47 ELECTROMAGNETIC DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 48 ULTRASOUND DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 49 EFFECTS OF LOW INTENSITY LASER THERAPY
TABLE 50 LLT THERAPY DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 51 WOUNDS CLASSIFIED ON THE BASIS OF SKIN LAYERS
TABLE 52 ACUTE WOUNDS CLASSIFIED ON THE BASIS OF MECHANISMS OF INJURY
TABLE 53 WORLD PREVALENCE DATA, BY TYPES OF WOUNDS, 2009 - 2016 (THOUSAND)
TABLE 54 STAGES OF PRESSURE ULCERS
TABLE 55 MARKET SHARE OF THERMAL INJURIES, 2010
TABLE 56 TYPES OF BURN & COMPLICATION RATES
TABLE 57 AGE AND BURN COMPLICATION RATES
TABLE 58 TOP TEN PROCEDURES FOR FLAME INJURIES
TABLE 59 RULE OF NINE CLASSIFICATION
TABLE 60 CLASSIFICATION OF BURNS, BY SKIN LAYERS
TABLE 61 CLASSIFICATION OF SURGICAL WOUNDS
TABLE 62 WOUND CARE MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 63 U.S.: WOUND CARE MARKET REVENUE, BY TYPES, 2009 – 2016 ($MILLION)
TABLE 64 U.S.: TRADITIONAL WOUND CARE MARKET REVENUE, BY TYPES, 2009 – 2016 ($MILLION)
TABLE 65 U.S.: ADVANCED WOUND CARE MARKET REVENUE, BY TYPES, 2009 – 2016 ($MILLION)
TABLE 66 U.S.: ACTIVE WOUND CARE MARKET REVENUE, BY TYPES, 2009 – 2016 ($MILLION)
TABLE 67 U.S.: WOUND CARE MARKET REVENUE, BY THERAPY DEVICES, 2009 - 2016 ($MILLION)
TABLE 68 EUROPE: WOUND CARE MARKET REVENUE, BY TYPES, 2009 - 2016 ($MILLION)
TABLE 69 EUROPE: TRADITIONAL WOUND CARE MARKET REVENUE, BY TYPES, 2009 - 2016 ($MILLION)
TABLE 70 EUROPE: ADVANCED WOUND CARE MARKET REVENUE, BY TYPES, 2009 – 2016 ($MILLION)
TABLE 71 EUROPE: ACTIVE WOUND CARE MARKET REVENUE, BY TYPES, 2009 – 2016 ($MILLION)
TABLE 72 EUROPE: WOUND CARE MARKET REVENUE, BY THERAPY DEVICES, 2009 - 2016 ($MILLION)
TABLE 73 ASIA: WOUND CARE MARKET REVENUE, BY TYPES, 2009 - 2016 ($MILLION)
TABLE 74 ASIA: TRADITIONAL WOUND CARE MARKET REVENUE, BY TYPES, 2009 - 2016 ($MILLION)
TABLE 75 ASIA: ADVANCED WOUND CARE MARKET, BY TYPES, 2009 - 2016 ($MILLION)
TABLE 76 ASIA: ACTIVE WOUND CARE MARKET REVENUE, BY TYPES, 2009 - 2016 ($MILLION)
TABLE 77 ASIA: WOUND CARE MARKET REVENUE, THERAPY DEVICES, 2009 - 2016 ($MILLION)
TABLE 78 ROW: WOUND CARE MARKET REVENUE, BY TYPES, 2009 - 2016 ($MILLION)
TABLE 79 ROW: TRADITIONAL WOUND CARE MARKET REVENUE, BY TYPES, 2009 - 2016 ($MILLION)
TABLE 80 ROW: ADVANCED WOUND CARE MARKET REVENUE, BY TYPES, 2009 – 2016 ($MILLION)
TABLE 81 ROW: ACTIVE WOUND CARE MARKET REVENUE, BY TYPES, 2009 - 2016 ($MILLION)
TABLE 82 ROW: WOUND CARE MARKET REVENUE, BY THERAPY DEVICES, 2009 - 2016 ($MILLION)
TABLE 83 MERGERS & ACQUISITIONS, 2009 –2012
TABLE 84 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, JOINT VENTURES, 2009 – 2012
TABLE 85 NEW PRODUCTS LAUNCH, 2009 – 2012
TABLE 86 EXPANSIONS, 2009 – 2012
TABLE 87 3M: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 88 3M: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 89 3M: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 90 BAXTER INTERNATIONAL: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 91 BAXTER INTERNATIONAL: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 92 BAXTER INTERNATIONAL: BIOSCIENCE SUB-SEGMENT REVENUE, 2009 - 2011 ($MILLION)
TABLE 93 BAXTER INTERNATIONAL: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 94 COLOPLAST A/S: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 95 COLOPLAST A/S: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 96 COLOPLAST A/S: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 97 CONVATEC HEALTHCARE B S.A.R.L: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 98 CONVATEC HEALTHCARE B S.A.R.L: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 99 CONVATEC HEALTHCARE B S.A.R.L: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 100 COVIDIEN PLC.: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 101 COVIDIEN PLC.: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 102 COVIDIEN PLC.: MEDICAL DEVICES REVENUE, BY SUB-SEGMENT, 2009 - 2011 ($MILLION)
TABLE 103 COVIDIEN PLC.: MEDICAL DEVICES REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 104 COVIDIEN PLC.: PHARMACEUTICAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 105 COVIDIEN PLC.: PHARMACEUTICAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 106 COVIDIEN PLC.: MEDICAL SUPPLIES REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 107 COVIDIEN PLC.: MEDICAL SUPPLIES REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 108 COVIDIEN PLC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 109 DERMA SCIENCES INC.: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 110 DERMA SCIENCES INC.: TOTAL REVENUE, BY SEGMENTS 2009 ($MILLION)
TABLE 111 DERMA SCIENCES INC.: TOTAL REVENUE, BY SEGMENTS, 2010 - 2011 ($MILLION)
TABLE 112 DERMA SCIENCES INC.: ADVANCED WOUND CARE MARKET, BY PRODUCTS, 2009 - 2011 ($THOUSAND)
TABLE 113 DERMA SCIENCES INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 114 HILL-ROM HOLDINGS, INC.: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 115 HILL-ROM HOLDINGS INC.: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 116 HILL-ROM HOLDINGS INC. : TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 117 HILL-ROM HOLDINGS INC: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 118 JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 119 JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011($MILLION)
TABLE 120 JOHNSON &.JOHNSON: CONSUMER SEGMENTS REVENUE, BY SUB-SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 121 JOHNSON & JOHNSON: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 122 KINETIC CONCEPTS, INC.: TOTAL REVENUE AND R&D EXPENSES, 2008 - 2010 ($MILLION)
TABLE 123 KINETIC CONCEPTS INC.: TOTAL REVENUE, BY SEGMENTS, 2008 - 2010 ($MILLION)
TABLE 124 KINETIC CONCEPTS INC.: TOTAL REVENUE, BY SEGMENTS, 2008 - 2010 ($MILLION)
TABLE 125 KINETIC CONCEPTS INC.: AHS NORTH AMERICA REVENUE, BY SEGMENT, 2008 - 2010 ($MILLION)
TABLE 126 KINETIC CONCEPTS INC.: AHS EMEA/APAC REVENUES, BY SEGMENTS, 2008 - 2010 ($MILLION)
TABLE 127 KINETIC CONCEPTS INC.: AHS REVENUE, BY GEOGRAPHY, 2008 - 2010 ($MILLION)
TABLE 128 KINETIC CONCEPTS INC.: LIFECELL REVENUE, BY GEOGRAPHY, 2008 - 2010 ($MILLION)
TABLE 129 KINETIC CONCEPTS INC.: TSS NORTH AMERICA REVENUE, BY SEGMENTS, 2008 - 2010 ($MILLION)
TABLE 130 KINETIC CONCEPTS INC.: TSS EMEA/APAC REVENUE, BY SEGMENTS, 2008 - 2010 ($MILLION)
TABLE 131 KINETIC CONCEPTS INC.: TSS REVENUE, BY SEGMENTS, 2008 - 2010 ($MILLION)
TABLE 132 KINETIC CONCEPTS INC.: TOTAL REVENUE, BY GEOGRAPHY, 2008 - 2010 ($MILLION)
TABLE 133 LABORATOIRES URGO: TOTAL REVENUE, 2009 - 2011 ($MILLION)
TABLE 134 LABORATOIRES URGO: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 135 MЦLNLYCKE HEALTH CARE AB: TOTAL REVENUE, 2008 - 2010 ($MILLION)
TABLE 136 MЦLNLYCKE HEALTH CARE AB: TOTAL REVENUE, BY SEGMENTS, 2010 ($MILLION)
TABLE 137 MЦLNLYCKE HEALTH CARE AB: TOTAL REVENUE, BY GEOGRAPHY, 2010 ($MILLION)
TABLE 138 HARTMANN AG: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 139 HARTMANN AG: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 140 HARTMANN AG: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 141 SHIRE PLC.: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 142 SHIRE PLC.: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 143 SHIRE PLC.: TOTAL REVENUE, BY PRODUCT SALES SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 144 SHIRE PLC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 145 SMITH & NEPHEW: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 146 SMITH & NEPHEW: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 147 SMITH & NEPHEW: REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 148 ULURU INC: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 149 ULURU INC: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 150 ULURU INC: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 151 WOUND MANAGEMENT TECHNOLOGIES, INC: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 1 WORLD WOUND CARE MARKET REVENUE, BY TYPES, 2009 – 2011 ($MILLION)
TABLE 2 WORLD TRADITIONAL WOUND CARE MARKET REVENUE, BY TYPES, 2009 – 2016 ($MILLION)
TABLE 3 TRADITIONAL WOUND CARE MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 4 WORLD WOUND CLOSURE MARKET REVENUE, BY TYPES, 2009 - 2016 ($MILLION)
TABLE 5 WOUND CLOSURE MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 6 WORLD SUTURES MARKET REVENUE, BY TYPES, 2009 – 2016 ($MILLION)
TABLE 7 WORLD SUTURES MARKET REVENUE, BY MATERIALS, 2009 - 2016 ($MILLION)
TABLE 8 TYPES OF SURGICAL SUTURES
TABLE 9 TYPE OF SUTURES & RAW MATERIALS
TABLE 10 CHARACTERISTICS OF ABSORBABLE SUTURES
TABLE 11 TYPES OF COMMERCIAL SUTURES
TABLE 12 CHARACTERISTICS OF SURGICAL SILK SUTURES
TABLE 13 CHARACTERISTICS OF SURGICAL COTTON SUTURE
TABLE 14 CHARACTERISTICS OF LINEN SUTURE
TABLE 15 TYPES & CHARACTERISTICS OF NON-ABSORBABLE SUTURES
TABLE 16 PARTS OF STAPLES
TABLE 17 WORLD TISSUE ADHESIVES, SEALANTS & GLUES MARKET REVENUE, BY PRODUCTS, 2009 – 2016 ($MILLION)
TABLE 18 ANTI-INFECTIVES MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 19 WORLD BASIC WOUND CARE MARKET REVENUE, BY TYPES, 2009 - 2016 ($MILLION)
TABLE 20 BASIC WOUND CARE MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 21 TYPES OF TAPES
TABLE 22 USES OF DRY DRESSING
TABLE 23 TYPES OF WOUND CLEANSERS
TABLE 24 WORLD ADVANCED WOUND CARE MARKET REVENUE, BY PRODUCTS, 2009 – 2016 ($MILLION)
TABLE 25 ADVANCED WOUND CARE MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 26 FILMS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 27 FOAM DRESSINGS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 28 FUNCTIONS OF COLLAGEN
TABLE 29 COLLAGEN MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 30 ALGINATES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 31 HYDROCOLLOIDS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 32 HYDROGELS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 33 WORLD ACTIVE WOUND CARE MARKET REVENUE, BY TYPES, 2009 – 2016 ($MILLION)
TABLE 34 ACTIVE WOUND CARE MARKET, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 35 TYPES OF SKIN GRAFTS
TABLE 36 COMMERCIAL SKIN SUBSTITUTES
TABLE 37 SKIN SUBSTITUTES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 38 TYPES OF GROWTH FACTORS
TABLE 39 GROWTH FACTOR MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 40 WORLD THERAPY DEVICES MARKET REVENUE, BY PRODUCTS, 2009 – 2016 ($MILLION)
TABLE 41 NPWT MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 42 PRESSURE RELIEF DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 43 ELECTRICAL STIMULATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 44 ULTRAVIOLET DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 45 HBOT MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 46 WHIRLPOOL THERAPY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 47 ELECTROMAGNETIC DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 48 ULTRASOUND DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 49 EFFECTS OF LOW INTENSITY LASER THERAPY
TABLE 50 LLT THERAPY DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 51 WOUNDS CLASSIFIED ON THE BASIS OF SKIN LAYERS
TABLE 52 ACUTE WOUNDS CLASSIFIED ON THE BASIS OF MECHANISMS OF INJURY
TABLE 53 WORLD PREVALENCE DATA, BY TYPES OF WOUNDS, 2009 - 2016 (THOUSAND)
TABLE 54 STAGES OF PRESSURE ULCERS
TABLE 55 MARKET SHARE OF THERMAL INJURIES, 2010
TABLE 56 TYPES OF BURN & COMPLICATION RATES
TABLE 57 AGE AND BURN COMPLICATION RATES
TABLE 58 TOP TEN PROCEDURES FOR FLAME INJURIES
TABLE 59 RULE OF NINE CLASSIFICATION
TABLE 60 CLASSIFICATION OF BURNS, BY SKIN LAYERS
TABLE 61 CLASSIFICATION OF SURGICAL WOUNDS
TABLE 62 WOUND CARE MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 63 U.S.: WOUND CARE MARKET REVENUE, BY TYPES, 2009 – 2016 ($MILLION)
TABLE 64 U.S.: TRADITIONAL WOUND CARE MARKET REVENUE, BY TYPES, 2009 – 2016 ($MILLION)
TABLE 65 U.S.: ADVANCED WOUND CARE MARKET REVENUE, BY TYPES, 2009 – 2016 ($MILLION)
TABLE 66 U.S.: ACTIVE WOUND CARE MARKET REVENUE, BY TYPES, 2009 – 2016 ($MILLION)
TABLE 67 U.S.: WOUND CARE MARKET REVENUE, BY THERAPY DEVICES, 2009 - 2016 ($MILLION)
TABLE 68 EUROPE: WOUND CARE MARKET REVENUE, BY TYPES, 2009 - 2016 ($MILLION)
TABLE 69 EUROPE: TRADITIONAL WOUND CARE MARKET REVENUE, BY TYPES, 2009 - 2016 ($MILLION)
TABLE 70 EUROPE: ADVANCED WOUND CARE MARKET REVENUE, BY TYPES, 2009 – 2016 ($MILLION)
TABLE 71 EUROPE: ACTIVE WOUND CARE MARKET REVENUE, BY TYPES, 2009 – 2016 ($MILLION)
TABLE 72 EUROPE: WOUND CARE MARKET REVENUE, BY THERAPY DEVICES, 2009 - 2016 ($MILLION)
TABLE 73 ASIA: WOUND CARE MARKET REVENUE, BY TYPES, 2009 - 2016 ($MILLION)
TABLE 74 ASIA: TRADITIONAL WOUND CARE MARKET REVENUE, BY TYPES, 2009 - 2016 ($MILLION)
TABLE 75 ASIA: ADVANCED WOUND CARE MARKET, BY TYPES, 2009 - 2016 ($MILLION)
TABLE 76 ASIA: ACTIVE WOUND CARE MARKET REVENUE, BY TYPES, 2009 - 2016 ($MILLION)
TABLE 77 ASIA: WOUND CARE MARKET REVENUE, THERAPY DEVICES, 2009 - 2016 ($MILLION)
TABLE 78 ROW: WOUND CARE MARKET REVENUE, BY TYPES, 2009 - 2016 ($MILLION)
TABLE 79 ROW: TRADITIONAL WOUND CARE MARKET REVENUE, BY TYPES, 2009 - 2016 ($MILLION)
TABLE 80 ROW: ADVANCED WOUND CARE MARKET REVENUE, BY TYPES, 2009 – 2016 ($MILLION)
TABLE 81 ROW: ACTIVE WOUND CARE MARKET REVENUE, BY TYPES, 2009 - 2016 ($MILLION)
TABLE 82 ROW: WOUND CARE MARKET REVENUE, BY THERAPY DEVICES, 2009 - 2016 ($MILLION)
TABLE 83 MERGERS & ACQUISITIONS, 2009 –2012
TABLE 84 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, JOINT VENTURES, 2009 – 2012
TABLE 85 NEW PRODUCTS LAUNCH, 2009 – 2012
TABLE 86 EXPANSIONS, 2009 – 2012
TABLE 87 3M: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 88 3M: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 89 3M: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 90 BAXTER INTERNATIONAL: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 91 BAXTER INTERNATIONAL: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 92 BAXTER INTERNATIONAL: BIOSCIENCE SUB-SEGMENT REVENUE, 2009 - 2011 ($MILLION)
TABLE 93 BAXTER INTERNATIONAL: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 94 COLOPLAST A/S: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 95 COLOPLAST A/S: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 96 COLOPLAST A/S: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 97 CONVATEC HEALTHCARE B S.A.R.L: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 98 CONVATEC HEALTHCARE B S.A.R.L: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 99 CONVATEC HEALTHCARE B S.A.R.L: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 100 COVIDIEN PLC.: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 101 COVIDIEN PLC.: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 102 COVIDIEN PLC.: MEDICAL DEVICES REVENUE, BY SUB-SEGMENT, 2009 - 2011 ($MILLION)
TABLE 103 COVIDIEN PLC.: MEDICAL DEVICES REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 104 COVIDIEN PLC.: PHARMACEUTICAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 105 COVIDIEN PLC.: PHARMACEUTICAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 106 COVIDIEN PLC.: MEDICAL SUPPLIES REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 107 COVIDIEN PLC.: MEDICAL SUPPLIES REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 108 COVIDIEN PLC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 109 DERMA SCIENCES INC.: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 110 DERMA SCIENCES INC.: TOTAL REVENUE, BY SEGMENTS 2009 ($MILLION)
TABLE 111 DERMA SCIENCES INC.: TOTAL REVENUE, BY SEGMENTS, 2010 - 2011 ($MILLION)
TABLE 112 DERMA SCIENCES INC.: ADVANCED WOUND CARE MARKET, BY PRODUCTS, 2009 - 2011 ($THOUSAND)
TABLE 113 DERMA SCIENCES INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 114 HILL-ROM HOLDINGS, INC.: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 115 HILL-ROM HOLDINGS INC.: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 116 HILL-ROM HOLDINGS INC. : TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 117 HILL-ROM HOLDINGS INC: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 118 JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 119 JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011($MILLION)
TABLE 120 JOHNSON &.JOHNSON: CONSUMER SEGMENTS REVENUE, BY SUB-SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 121 JOHNSON & JOHNSON: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 122 KINETIC CONCEPTS, INC.: TOTAL REVENUE AND R&D EXPENSES, 2008 - 2010 ($MILLION)
TABLE 123 KINETIC CONCEPTS INC.: TOTAL REVENUE, BY SEGMENTS, 2008 - 2010 ($MILLION)
TABLE 124 KINETIC CONCEPTS INC.: TOTAL REVENUE, BY SEGMENTS, 2008 - 2010 ($MILLION)
TABLE 125 KINETIC CONCEPTS INC.: AHS NORTH AMERICA REVENUE, BY SEGMENT, 2008 - 2010 ($MILLION)
TABLE 126 KINETIC CONCEPTS INC.: AHS EMEA/APAC REVENUES, BY SEGMENTS, 2008 - 2010 ($MILLION)
TABLE 127 KINETIC CONCEPTS INC.: AHS REVENUE, BY GEOGRAPHY, 2008 - 2010 ($MILLION)
TABLE 128 KINETIC CONCEPTS INC.: LIFECELL REVENUE, BY GEOGRAPHY, 2008 - 2010 ($MILLION)
TABLE 129 KINETIC CONCEPTS INC.: TSS NORTH AMERICA REVENUE, BY SEGMENTS, 2008 - 2010 ($MILLION)
TABLE 130 KINETIC CONCEPTS INC.: TSS EMEA/APAC REVENUE, BY SEGMENTS, 2008 - 2010 ($MILLION)
TABLE 131 KINETIC CONCEPTS INC.: TSS REVENUE, BY SEGMENTS, 2008 - 2010 ($MILLION)
TABLE 132 KINETIC CONCEPTS INC.: TOTAL REVENUE, BY GEOGRAPHY, 2008 - 2010 ($MILLION)
TABLE 133 LABORATOIRES URGO: TOTAL REVENUE, 2009 - 2011 ($MILLION)
TABLE 134 LABORATOIRES URGO: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 135 MЦLNLYCKE HEALTH CARE AB: TOTAL REVENUE, 2008 - 2010 ($MILLION)
TABLE 136 MЦLNLYCKE HEALTH CARE AB: TOTAL REVENUE, BY SEGMENTS, 2010 ($MILLION)
TABLE 137 MЦLNLYCKE HEALTH CARE AB: TOTAL REVENUE, BY GEOGRAPHY, 2010 ($MILLION)
TABLE 138 HARTMANN AG: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 139 HARTMANN AG: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 140 HARTMANN AG: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 141 SHIRE PLC.: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 142 SHIRE PLC.: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 143 SHIRE PLC.: TOTAL REVENUE, BY PRODUCT SALES SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 144 SHIRE PLC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 145 SMITH & NEPHEW: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 146 SMITH & NEPHEW: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 147 SMITH & NEPHEW: REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 148 ULURU INC: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 149 ULURU INC: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 150 ULURU INC: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 151 WOUND MANAGEMENT TECHNOLOGIES, INC: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
LIST OF FIGURES
FIGURE 1 EVOLUTION OF WOUND CARE
FIGURE 2 WOUND CARE MARKET SEGMENTATION
FIGURE 3 MARKET DYNAMICS
FIGURE 4 WOUND CARE MARKET: END-USER ANALYSIS, 2011
FIGURE 5 WORLD WOUND CARE MARKET SHARE ANALYSIS, BY PLAYERS, 2011
FIGURE 6 FIBRIN SEALANT ACTIVATION MECHANISM
FIGURE 7 U.S.: MARKET SHARE ANALYSIS, BY PLAYERS, 2011
FIGURE 8 EUROPE: WOUND CARE MARKET SHARE ANALYSIS, BY PLAYERS, 2011
FIGURE 9 ASIA: WOUND MARKET SHARE ANALYSIS, 2011
FIGURE 10 KEY GROWTH STRATEGIES, JANUARY 2009 - APRIL 2012
FIGURE 1 EVOLUTION OF WOUND CARE
FIGURE 2 WOUND CARE MARKET SEGMENTATION
FIGURE 3 MARKET DYNAMICS
FIGURE 4 WOUND CARE MARKET: END-USER ANALYSIS, 2011
FIGURE 5 WORLD WOUND CARE MARKET SHARE ANALYSIS, BY PLAYERS, 2011
FIGURE 6 FIBRIN SEALANT ACTIVATION MECHANISM
FIGURE 7 U.S.: MARKET SHARE ANALYSIS, BY PLAYERS, 2011
FIGURE 8 EUROPE: WOUND CARE MARKET SHARE ANALYSIS, BY PLAYERS, 2011
FIGURE 9 ASIA: WOUND MARKET SHARE ANALYSIS, 2011
FIGURE 10 KEY GROWTH STRATEGIES, JANUARY 2009 - APRIL 2012
